timolol has been researched along with albuterol in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (51.61) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Diamond, GR; Langham, ME; Pollack, IP; Radius, RL | 1 |
| Barradas, MA; Dandona, P; Khokher, MA; Mikhailidis, DP; Turaihi, K | 1 |
| Chiou, GC; Liu, HK; McLaughlin, MA; Watanabe, K | 1 |
| Keshmirian, J; Nogrady, T | 1 |
| Richards, R; Tattersfield, AE | 1 |
| Phylactos, AC | 1 |
| Spence, JD; Wong, DG | 1 |
| Araie, M | 1 |
| Colasanti, BK; Trotter, RR | 1 |
| Cerino, D; Kling, P; Lotti, VJ | 1 |
| Clark, B; Trope, GE | 1 |
| Miichi, H; Nagataki, S | 2 |
| Brown, MJ; Dickerson, JE; Ferro, A; Hall, JA | 1 |
| Hashimoto, T; Kitazawa, Y; Taniguchi, T; Toyoda, Y | 1 |
| Lu, WY; Wei, G; Zheng, JM | 1 |
2 review(s) available for timolol and albuterol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for timolol and albuterol
| Article | Year |
|---|---|
Timolol. A new drug for management of chronic simple glaucoma.
Topics: Adult; Aged; Albuterol; Animals; Epinephrine; Glaucoma; Hemodynamics; Humans; Intraocular Pressure; Middle Aged; Norepinephrine; Pilocarpine; Propanolamines; Rabbits; Timolol | 1978 |
Comparison of the airway response to eye drops of timolol and its isomer L-714,465 in asthmatic subjects.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Bronchi; Dose-Response Relationship, Drug; Forced Expiratory Volume; Humans; Ipratropium; Isomerism; Middle Aged; Ophthalmic Solutions; Timolol | 1987 |
Amiloride with or without salbutamol versus placebo: effects on lipoproteins in hypertensive patients treated with timolol-hydrochlorothiazide.
Topics: Albuterol; Amiloride; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins; Timolol | 1986 |
A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Exercise; Heart Rate; Humans; Male; Phenylephrine; Prospective Studies; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Timolol | 1997 |
25 other study(ies) available for timolol and albuterol
| Article | Year |
|---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Sympathomimetic and sympatholytic drugs in the therapy of glaucoma (author's transl)].
Topics: Albuterol; Clonidine; Epinephrine; Glaucoma; Humans; Isoproterenol; Norepinephrine; Propranolol; Sympatholytics; Sympathomimetics; Timolol | 1977 |
86Rb(K) influx and [3H]ouabain binding by human platelets: evidence for beta-adrenergic stimulation of Na-K ATPase activity.
Topics: Adult; Albuterol; Atenolol; Biological Transport, Active; Blood Platelets; Cell Membrane; Epinephrine; Humans; Isoproterenol; Norepinephrine; Ouabain; Phentolamine; Potassium; Receptors, Adrenergic, beta; Rubidium Radioisotopes; Sodium-Potassium-Exchanging ATPase; Timolol; Tritium | 1989 |
Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Aqueous Humor; Butoxamine; Cats; Dihydroalprenolol; Female; Intraocular Pressure; Male; Metoprolol; Propanolamines; Propranolol; Timolol | 1985 |
Rotifer neuropharmacology--III. Adrenergic drug effects on Brachionus plicatilis.
Topics: Albuterol; Animals; Cilia; Dose-Response Relationship, Drug; Isoproterenol; Movement; Norepinephrine; Phenylephrine; Propranolol; Receptors, Adrenergic; Rotifera; Timolol; Tolazoline | 1987 |
Timolol inhibits adenylate cyclase activity in the iris-ciliary body and trabecular meshwork of the eye and blocks activation of the enzyme by salbutamol.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Albuterol; Animals; Cattle; Ciliary Body; Cyclic AMP; Enzyme Activation; Octoxynol; Polyethylene Glycols; Rabbits; Timolol; Trabecular Meshwork | 1986 |
Time change of rabbit aqueous flow under influence of adrenergic drugs.
Topics: Acetazolamide; Albuterol; Animals; Aqueous Humor; Female; Flurbiprofen; Male; Phenylephrine; Rabbits; Sympatholytics; Sympathomimetics; Time Factors; Timolol | 1985 |
Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Carbachol; Cats; Dose-Response Relationship, Drug; Echothiophate Iodide; Eye; Female; Intraocular Pressure; Male; Sympathectomy; Timolol | 1981 |
High and low (Gpp(NH)p-sensitive) affinity sites for beta 2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferens.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Electric Stimulation; Guanosine Triphosphate; Guanylyl Imidodiphosphate; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Timolol; Vas Deferens | 1982 |
Beta adrenergic receptors in pigmented ciliary processes.
Topics: Albuterol; Animals; Cell Membrane; Ciliary Body; In Vitro Techniques; Male; Pigmentation; Pindolol; Practolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Sheep; Timolol | 1982 |
Effects of pilocarpine, salbutamol, and timolol on aqueous humor formation in cynomolgus monkeys.
Topics: Albuterol; Animals; Aqueous Humor; Female; Fluoresceins; Intraocular Pressure; Macaca; Macaca fascicularis; Pentobarbital; Pilocarpine; Propanolamines; Time Factors; Timolol; Urethane | 1983 |
Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye.
Topics: Albuterol; Animals; Aqueous Humor; Atropine; Epinephrine; Female; Intraocular Pressure; Isoproterenol; Male; Norepinephrine; Parasympathomimetics; Physostigmine; Pilocarpine; Propranolol; Rabbits; Sympathomimetics; Timolol | 1982 |
Respiratory and cardiovascular effects of WP-934 in guinea pigs.
Topics: Acetylcholine; Administration, Topical; Adrenergic beta-Antagonists; Albuterol; Aminophylline; Animals; Blood Pressure; Bronchoconstriction; Cardiovascular System; Dose-Response Relationship, Drug; Gels; Guinea Pigs; Heart Rate; Histamine; Male; Ophthalmic Solutions; Respiratory System; Timolol | 2001 |
[Diffusion behaviors of drugs in thermosensitive in situ gels].
Topics: Albuterol; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Gels; Poloxamer; Propranolol; Surface-Active Agents; Timolol | 2004 |